The Current Ratio as of November 2024 (TTM) for Tempest Therapeutics, Inc. (TPST) is 1.69

According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.69. This represents a change of -40.20% compared to the average of 2.82 of the last 4 quarters.

Tempest Therapeutics, Inc. (TPST) Historical Current Ratio (quarterly & annually)

How has TPST Current Ratio performed in the past?

The mean historical Current Ratio of Tempest Therapeutics, Inc. over the last ten years is 6.39. The current 1.69 Current Ratio has changed 2.54% with respect to the historical average. Over the past ten years (40 quarters), TPST's Current Ratio was at its highest in in the March 2015 quarter at 25.92. The Current Ratio was at its lowest in in the March 2020 quarter at 0.29.

Tempest Therapeutics, Inc. (TPST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tempest Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tempest Therapeutics, Inc. (TPST) Average Current Ratio

How has TPST Current Ratio performed in the past?

The current Current Ratio of Tempest Therapeutics, Inc. (TPST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tempest Therapeutics, Inc. (TPST) Current Ratio vs. Peers

How is TPST’s Current Ratio compared to its peers?

Tempest Therapeutics, Inc.’s Current Ratio is less than Indaptus Therapeutics, Inc. (3.42), less than Rezolute, Inc. (13.79), greater than Comera Life Sciences Holdings, Inc. (0.90), less than Forte Biosciences, Inc. (2.06), less than Sana Biotechnology, Inc. (4.47), less than Olema Pharmaceuticals, Inc. (7.10), less than Cullinan Oncology, Inc. (24.46), less than aTyr Pharma, Inc. (6.07), less than Zentalis Pharmaceuticals, Inc. (7.29), less than Lyell Immunopharma, Inc. (13.43), less than Monte Rosa Therapeutics, Inc. (6.03), less than Theseus Pharmaceuticals, Inc. (29.93), less than Revolution Medicines, Inc. (14.24), greater than ZIVO Bioscience, Inc. (0.17), less than RenovoRx, Inc. (5.40), less than Ikena Oncology, Inc. (15.32), greater than Catalyst Biosciences, Inc. (0), greater than Akari Therapeutics, Plc (0.29), greater than Armata Pharmaceuticals, Inc. (0.19), less than Anebulo Pharmaceuticals, Inc. (3.45), greater than Scopus BioPharma Inc. (0.05), less than Processa Pharmaceuticals, Inc. (3.97),

Build a custom stock screener for Tempest Therapeutics, Inc. (TPST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tempest Therapeutics, Inc. (TPST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.